- With Mayo Clinic diabetes educators
Nancy Klobassa Davidson, R.N., and Peggy Moreland, R.N.
read biographyclose windowBiography of
Nancy Klobassa Davidson, R.N., and Peggy Moreland, R.N.
Nancy Klobassa Davidson and Peggy Moreland
Nancy Klobassa Davidson, R.N., B.S.N, C.D.E
Nancy Klobassa Davidson is a registered nurse who has worked in diabetes education for 17 years. She is a certified diabetes educator (C.D.E.) and is currently in graduate school working on a Master of Science in nursing (M.S.N.) and health care education.Nancy works with adults who have type 1, type 2 and other forms of diabetes. Nancy is coordinator of the Diabetes Unit's intensive insulin therapy program within the Division of Endocrinology, Diabetes, Metabolism, & Nutrition at Mayo Clinic in Rochester, Minn. Nancy has worked extensively with insulin pump therapy and continuous interstitial glucose sensing.
Peggy Moreland, R.N., M.S.N.
Peggy Moreland is a certified diabetes educator (C.D.E.) in the Division of Endocrinology, Diabetes, Metabolism, & Nutrition at Mayo Clinic in Rochester, Minn.Peggy graduated with a Master of Science in Nursing and Health Care Education from the University of Phoenix and is a member of the American Association of Diabetes Educators and the American Diabetes Association. A certified diabetes educator (C.D.E.), Peggy enjoys working with patients to set and achieve diabetes self-management goals.
Latest entries
- Diabetes etiquette: When you don't have diabetes
May 2, 2013
- Coping with diabetes: Helping your loved one
April 24, 2013
- Types of diabetes
March 16, 2013
- Taking diabetes drugs
Feb. 27, 2013
- Insulin or medication?
Feb. 13, 2013
Free
E-newsletter
Subscribe to Housecall
Our weekly general interest
e-newsletter keeps you up to date
on a wide variety of health topics.
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Living with diabetes blog
-
Dec. 4, 2009
Insulin devices being discontinued
By Nancy Klobassa Davidson, R.N., and Peggy Moreland, R.N.
Several insulin delivery devices are being discontinued by a major insulin manufacturer. On Jan. 1, 2010, the Novolin Innolet R, Innolet N, Innolet 70/30, and any of the Novolin Pen fills, except the Novolog Pen fill, will no longer be available.
This will be difficult for those of you who depend on these insulin devices to manage diabetes. The prefilled Flex pen is a great device and is easier to use than the Pen fill cartridge pens, but it doesn't come with NPH insulin. The Innolet is also a great pen device. In fact, when it first came out I often said it was the best thing since sliced bread to happen to diabetes education.
I have a patient with severe rheumatoid arthritis who's on twice- a-day NPH insulin program. The only way she can give her own injections is with the Innolet pen. She has tried the other NPH pen and is unable to manage it. She's at the point where she may need to hire a nursing service and have a nurse come into her home to give her injections twice a day. This is a major expense and she'd lose her independent living. A number of our patients have dexterity issues and the Innolet has been an extremely useful tool. I've also found it useful for illiterate clients and individuals with poor eyesight.
The same company will only have NPH insulin available in a vial. This means that a healthcare provider will have to order the NPH for their patients as vial/syringes, write a prescription for the other major insulin company's NPH pen, or switch to another insulin program. All these options do come with some obstacles.
- Many insurance providers contract with a specific pharmaceutical company and if the product isn't on their formulary, it isn't covered or is covered at higher co-pay.
- The insulin programs using basal/bolus insulin are more complex and can involve multiple daily injections and blood glucose monitoring.
- Analog insulin is more expensive then NPH.
- The insulin action of NPH insulin provides better coverage and is a simpler insulin program for specific health conditions; patients on chemotherapy or steroids, such as prednisone.
The bottom line — talk to your health care provider about your options.
Have a great week!
Regards,
Nancy
15 comments posted
Share on:
15 comments posted